Are Investors Undervaluing Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) By 31%?

Simply Wall StDec 27 07:29 ET

Insider Purchase: Director at $IONS (IONS) Buys 2,500 Shares

Quiver QuantitativeDec 26 17:01 ET

Analysts Offer Insights on Healthcare Companies: 60 Degrees Pharmaceuticals, Inc. (SXTP), Ionis Pharmaceuticals (IONS) and Zura Bio (ZURA)

TipRanksDec 25 06:51 ET · Ratings

PANTHERx Rare Selected by Ionis as Specialty Pharmacy for TRYNGOLZA (Olezarsen)

PR NewswireDec 23 08:42 ET

Piper Sandler Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $62

Moomoo NewsDec 23 07:31 ET · Ratings

Barclays Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Maintains Target Price $51

Moomoo NewsDec 23 05:31 ET · Ratings